Why is Godavari Drugs falling/rising?

As of 10-Jul, Godavari Drugs Ltd is currently priced at 90.30, reflecting an increase of 0.43 or 0.48%. Despite this slight uptick, the stock has shown a negative performance over the past week, down 0.77%, and a significant decline of 6.60% over the past month. The stock is trading below all its moving averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 18.02% against the 5-day average. The stock's performance over the past year has also been poor, generating a return of -11.47%, while profits have decreased by 22.1%. Although the company has an attractive valuation with a return on capital employed (ROCE) of 12.3 and is trading at a discount compared to peers, the overall weak long-term fundamentals and high debt levels raise concerns.
In the broader market context, the Sensex has shown a slight decline of 0.06% over the past week, which suggests that the market is relatively stable compared to Godavari Drugs' performance. However, the stock has underperformed the benchmark significantly over the longer term, with a year-to-date decline of 17.42% compared to the Sensex's increase of 6.46%. This underperformance, combined with the company's weak operating profit growth and high debt-to-EBITDA ratio, indicates that investor sentiment may be cautious, contributing to the stock's recent price movements.